Member Info for PI100

Chrisdr - remind what price GM bought at? Ok it was likely smoke and mirrors and he didn’t do badly out of it. However, that suggests we very much can take little notice of director buys.
They could have bought in simply to shut up shareholders for a bit, rather than giving any actual news.

HarChris from what you’ve seen do you have any faith in that happening? Ignore the directors buys as they’re smoke and mirrors (they’ll compensate themselves via bumper salaries). What is making you remain invested? Or keen to trade.

DRB - we will see. Look at what has been delayed so far. I promise not to mention it again. However when the delays are confirmed, I will be saying I told you so.

DRB- I’ve been burned and have no interest in buying individual shares now. My investments for 22/23 are limited to £4k for my LISA so that’s covered already therefore no need to sell at such a huge loss. Doubt it’ll go much higher but willing to see what the end of April update says.

Sell

My point is covid is done from a money spinning perspective here. They say 50% reduction, it’ll be 60-65%. As for Q4, not a chance, we all know that.

No thanks, my only transactions in ncyt will be well.

But there’s **** all demand for it. It’s April 2022, covid is done and dusted. Do you honestly think it will have a materially positive impact on the bottom line?

Too little, too late.

Kaeren - good news? We’re down 4% on the news.

BYP absolutely spot on. It’s almost like critical analysis of the company’s actions (and BOD inactivity) is only allowed if it is Uber positive (even when there is absolutely **** all positive news coming out).

Why would I? Sending them emails is not my bag, it achieves nothing. Having a moan and rant on here is different as most of us are in the same boat.

It’s quite clear that covid rns’ are not wanted nowadays.

What strategy? We’ve just been told that demand for our products is massively diminishing (puts paid to the hope that we had a good Q1 from omicron.) Unless they’ve got some proper aces up their sleeves (LOL) I expect to see the covid revenue drop be revised to north of 50%. I think a couple of weeks could be a bridge too far for most long suffering shareholders.

Rifleman - not a chance. Why are figures such as £15 still being bandied around?

DRB recovery from what? We bounced back from mid £1’s and sub cash balance but surely this is just par now? Covid is done and all we know is we may have some non covid stuff in q4 (which we won’t as it’ll be delayed).

I don’t understand what we are recovering from any more, £160m marcap for a firm with massively dwindling sales probably isn’t that bad.

Slightly concerning that we’re in Q2 and still RNS’ing about covid tests which no one cares about. It’s all about non covid, that’s the update we need. Covid test rns’ are very 2020.

To be fair the last time he came out with a big announcement we tanked over 20% that day, so maybe silence is good.

Jesus wept, 70 trades today. Does anyone know we even exist?

Was their dispute comparable to ours? If so, fingers crossed!

What is?

Encourage all friends and family to get the jab and live life,
Kettle

Problem is if we get another 7-10 of these until news day.